OptiPranolol

OptiPranolol is a brand name of metipranolol ophthalmic, approved by the FDA in the following formulation(s):

OPTIPRANOLOL (metipranolol hydrochloride - solution/drops; ophthalmic)

• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: December 29, 1989
  
  Strength(s): 0.3% ^[RLD][AT]

Has a generic version of OptiPranolol been approved?

Yes. The following products are equivalent to OptiPranolol:

METIPRANOLOL (metipranolol hydrochloride solution/drops; ophthalmic)

• 
  Manufacturer: FALCON PHARMS
  
  Approval date: August 6, 2001
  
  Strength(s): 0.3% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of OptiPranolol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with OptiPranolol.

See also...

• OptiPranolol Drops Consumer Information (Wolters Kluwer)
• OptiPranolol Consumer Information (Cerner Multum)
• Optipranolol Advanced Consumer Information (Micromedex)
• Metipranolol Drops Consumer Information (Wolters Kluwer)
• Metipranolol ophthalmic Consumer Information (Cerner Multum)
• Metipranolol Ophthalmic Advanced Consumer Information (Micromedex)